Mind Medicine Inc (NAS:MNMD)
$ 7.99 -0.27 (-3.27%) Market Cap: 585.92 Mil Enterprise Value: 334.01 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 41/100

Q1 2024 Mind Medicine (MindMed) Inc Earnings Call Transcript

May 08, 2024 / 08:30PM GMT
Release Date Price: $9.61 (+0.63%)
Operator

Good day, and thank you for standing by. Welcome to the MindMed Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Rob Barrow, CEO of MindMed. Please go ahead.

Robert Barrow Mind Medicine;MindMed;Inc.;CEO

()-

Thank you, and good afternoon, everyone. Welcome to our first quarter 2024 financial results and corporate update conference call. The press release reporting our financial results is available in the Investors and Media section of our website, and our quarterly report on Form 10-Q for the quarter ended March 31, 2024, is being filed today with the Securities and Exchange Commission.

During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot